Research progress of Hodgkin lymphoma
10.3760/cma.j.issn.1009-9921.2014.05.015
- VernacularTitle:霍奇金淋巴瘤的研究进展
- Author:
Wenli WAN
;
Lei TIAN
- Publication Type:Journal Article
- Keywords:
Hodgkin lymphoma;
Pathogenesis;
Prognosis;
Treatment
- From:
Journal of Leukemia & Lymphoma
2014;23(5):308-311
- CountryChina
- Language:Chinese
-
Abstract:
Hodgkin lymphoma (HL) is a type of malignant tumor originating from the lymphoid hematopoietic tissues.Its typical pathological feature is the existence of R-S cells in the background of the different types of inflammatory cells.HL represents about 10 ％ of the total lymphoma and has good treatment outcome with 80 ％-90 ％ cure rate.However,there are still about 10 ％ of patients with refractory or relapsed lymphoma,which has become research focus of HL.In recent years,along with the application of molecular biology techniques,radiotherapy,chemotherapy and targeted therapy in treating HL,significant progress has been made in pathogenesis,prognosis and treatment of HL.
